Injective has signed an early-stage memorandum of understanding with South Korean custodian BDACS to make BDACS-issued KRW1 the exclusive Korean won settlement asset for tokenized real-world assets on Injective. The agreement does not mean the system is operating: implementation depends on regulatory clearance, institutional onboarding and KRW1-settled volumes. Minting and redemption are initially limited to approved institutional partners and remain subject to regulatory approval.
BDACS says KRW1 is backed one-to-one by Korean won held at a major South Korean bank. The partners aim to provide a won-denominated alternative to dollar stablecoins for tokenized-asset settlement, but the source gives no launch date.
